Techno-Science.net on MSN
💊 Pharmaceutical AIs are bluffing, scientists sound the alarm
The most advanced artificial intelligence programs are now capable of significantly accelerating pharmaceutical research by ...
The field of biotechnology has always transformed cutting-edge science into life-changing medicines, but today that transformation is happening at a staggering pace.
Before he launched a biotech startup, prior even to landing a role in a premier academic lab, Anindya Roy arrived in the U.S.
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...
Movement toward developing a robust, internationally active biotechnology industry is gaming momentum in the People’s Republic of China.. And as the movement picks up steam, one byproduct is an ...
SAN DIEGO--(BUSINESS WIRE)--Scientist.com, the world’s leading marketplace for biopharma research, today announced the launch of a new large language model (LLM)-powered research assistant called ...
Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and ...
"I think I can," Tom Pickens, CEO of a spaceflight services company-turned biotech called SPACEHAB, told Congress. SPACEHAB has been sending up science payloads for the past 23 years. The company has ...
MSLs Have Role in Developing & Refining Business Strategy & Commercializing Products Last December, an article in this publication listed medical science liaisons (MSLs) among the hot jobs in ...
LCGC International Column Editor Michael Dong concludes his three-part series on HPLC fundamentals for practicing scientists with a case study concerning pharmaceutical development using UHPLC.
Biotech success isn’t just about great science—it’s about building a compelling commercial narrative from day one. In today’s challenging funding landscape, investors and partners demand more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results